Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

Implementation and Real-World Outcomes of [177Lu]Lu-PSMA-617 for Metastatic Androgen Pathway Modulation-Resistant Prostate Cancer: Following Public Reimbursement in Canada

[177Lu]Lu-PSMA-617 improves outcomes in patients with PSMA-positive metastatic Androgen Pathway Modulation-Resistant prostate cancer (mAPMR) previously treated with androgen deprivation therapy, androgen receptor pathway inhibitors and taxane chemotherapy; however, Canadian real-world data following public reimbursemen...

D. Jiang, P. Veit-Haibach, U. Metser et al. · 0 citations
Review Open access Nov 2026

PSMA-Targeted Radioligand Therapy for Androgen Pathway Modulation-Resistant Prostate Cancer (APMR) in the Chemotherapy-Naïve Setting: A Narrative Review and Expert Commentary

This review examines the emerging evidence supporting the use of PSMA-targeted RLT in select patients with chemotherapy-naïve APMR, its potential role within current treatment pathways, and key considerations for patient selection, treatment sequencing, and the involvement of an experienced medical oncologist within a...

D. Jiang, K. Chi, U. Emmenegger et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.